Search - tctmd.com

Displaying 821 - 840 of 2472

Sort: Relevancy | Date

Presentation TCT 2015

Access Site Alternatives for Transcatheter MV Replacement: Transatrial, Transapical, or Transeptal?

Presenter: Michael J. Mack, Francesco Maisano, Nicolo Piazza

October 12, 2015

Presentation TCT 2015

Is Hemodynamic Collapse Due to Increased Afterload After MV Replacement in Severe MR With Reduced LVEF a Real Phenomenon?

Presenter: Michael J. Mack, Francesco Maisano, Patrick M. McCarthy

October 12, 2015

Presentation TCT 2015

For Years Weve Been Hearing Surgical MV Repair Is Always Preferable to Replacement So, Why Transcatheter MV Replacement?!

Presenter: Michael J. Mack, Francesco Maisano, John G. Webb

October 12, 2015

Presentation TCT 2015

Severe LV Dysfunction and TAVR: Case Presentation

Presenter: Robert O. Bonow, Allan Schwartz, Kendra J. Grubb

October 12, 2015

Presentation TCT 2015

Transcatheter Annuloplasty and Mitral Valve Replacement: Emerging Therapeutic Options

Presenter: Blase A. Carabello, Howard C. Herrmann

October 12, 2015

Presentation TCT 2015

Transcatheter Mitral Therapies in 2015: MitraClip in Trials and the Real World

Presenter: Blase A. Carabello, Howard C. Herrmann, Ted E. Feldman

October 12, 2015

Presentation TCT 2015

CoreValve US Extreme Risk: Evaluation of a Self-Expanding Transcatheter Aortic Valve in Patients With Severe Aortic Stenosis at Extreme Risk for Surgery

Presenter: Spencer B. King III, Jagat Narula, James B. Hermiller Jr

October 12, 2015

News Industry News

STENTYS Sirolimus-Eluting Stent Confirms Best-in-Class Performance at 3 Years(1)

October 12, 2015

News Industry News

Mitralign to Provide Update on Transcatheter Tricuspid Repair at TCT 2015

October 12, 2015

News Industry News

Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants

October 12, 2015

News Industry News

Follow-up imaging data from APPOSITION IV study to be presented at TCT conference in San Francisco

October 12, 2015

News Industry News

First-In-Man Study Examines Angiographic And Clinical Outcomes Of Newest Bioresorbable Magnesium Stent

October 12, 2015

News Conference News TCT 2015

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

October 12, 2015

News Conference News TCT 2015

DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year

October 12, 2015

News Conference News TCT 2015

CoreValve Extreme Risk Pivotal Trial: Improved Benefits Confirmed After 3 Years

October 12, 2015

News Industry News

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

October 12, 2015

News Industry News

Accessing the Heart Via the Arm During AD-HOC PCI has Similar Ischemic Outcomes Compared to Conventional Groin Access at One Year with Potential for Lower Bleeding

October 12, 2015

News Industry News

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

October 12, 2015

News Industry News

ABSORB II: Two-Year Data From The First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes

October 12, 2015

Presentation TCT 2015

Development of TAVR in China: Clinical Data and Experience

Presenter: Run-Lin Gao, Martin B. Leon, Bo Xu, Yuejin Yang

October 11, 2015

Advertisement

Access Site Alternatives for Transcatheter MV Replacement: Transatrial, Transapical, or Transeptal?

Is Hemodynamic Collapse Due to Increased Afterload After MV Replacement in Severe MR With Reduced LVEF a Real Phenomenon?

For Years Weve Been Hearing Surgical MV Repair Is Always Preferable to Replacement So, Why Transcatheter MV Replacement?!

Severe LV Dysfunction and TAVR: Case Presentation

Transcatheter Annuloplasty and Mitral Valve Replacement: Emerging Therapeutic Options

Transcatheter Mitral Therapies in 2015: MitraClip in Trials and the Real World

CoreValve US Extreme Risk: Evaluation of a Self-Expanding Transcatheter Aortic Valve in Patients With Severe Aortic Stenosis at Extreme Risk for Surgery

STENTYS Sirolimus-Eluting Stent Confirms Best-in-Class Performance at 3 Years(1)

Mitralign to Provide Update on Transcatheter Tricuspid Repair at TCT 2015

Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants

Follow-up imaging data from APPOSITION IV study to be presented at TCT conference in San Francisco

First-In-Man Study Examines Angiographic And Clinical Outcomes Of Newest Bioresorbable Magnesium Stent

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year

CoreValve Extreme Risk Pivotal Trial: Improved Benefits Confirmed After 3 Years

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

Accessing the Heart Via the Arm During AD-HOC PCI has Similar Ischemic Outcomes Compared to Conventional Groin Access at One Year with Potential for Lower Bleeding

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

ABSORB II: Two-Year Data From The First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes

Development of TAVR in China: Clinical Data and Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content